placental remnants or residual trophoblastic tissue
Conditions
Interventions
Patients are randomized between HM or ultrasound guided EVA.
Patients in the observational prospective study will receive the treatment of
their choice: HM or ultrasound guided EVA.
Sponsors
Catharina-ziekenhuis
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Ultrasonographic findings: image suggestive for placental remnants ranging from 1 to 4 cm in diameter
Exclusion criteria
Exclusion criteria: Placental remnants with a maximum diameter smaller than 1 cm or more than 4 cm Patients presenting with fever Visual or pathological (e.g. on biopsy) evidence of malignancy preoperatively or at the time of operation Untreated cervical stenosis making safe uterine access impossible as diagnosed preoperatively by ambulant hysteroscopy A contra-indication for surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IUA at follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Installation and operating time - Conversion rates - Peri- and postoperative complications (e.g. excessive fluid deficit in case of hysteroscopy, perforation, hemorrhage, postoperative infection) - Availability of tissue for pathology analysis and pathology results - Completeness of removal at second look hysteroscopy - Persistence of symptoms - Necessity for additional treatment - Reduction of unnecessary interventions | — |
Countries
Netherlands
Outcome results
None listed